Anavex Life Sciences Corp (AVXL)

[falconer66a]

Anavex Solely Dependent on an Alzheimer’s Fix?

Ok, what if the new Alzheimer’s vaccine a) really works; prevents the disease, b) has double-blind, placebo-controlled Phase III clinical trials that happen quickly (within a year), and then, c) becomes the new standard of care (well, prevention) of Alzheimer’s, what would Anavex Life Sciences Corp be left with?

1. A Rett syndrome therapy (very small market for such).

2. A Parkinson’s dementia therapy (a gigantic market).

3. A Fragile-X therapy (market size undetermined; small).

4. An insomnia therapy (gigantic market).

Others yet to be tested in the Anavex pipeline.